Back to Search
Start Over
Influenza A/H1N1 2009 pneumonia in kidney transplant recipients: characteristics and outcomes following high-dose oseltamivir exposure.
- Source :
-
Transplant infectious disease : an official journal of the Transplantation Society [Transpl Infect Dis] 2010 Apr; Vol. 12 (2), pp. 127-31. Date of Electronic Publication: 2010 Jan 20. - Publication Year :
- 2010
-
Abstract
- We report 2 cases of severe pneumonia due to the novel pandemic influenza A/H1N1 2009 in kidney transplant recipients. Our patients initially experienced influenza-like illness that rapidly progressed to severe pneumonia within 48 h. The patients became hypoxic and required non-invasive ventilation. The novel influenza A/H1N1 2009 was identified from their nasal swabs. These cases were treated successfully with a relatively high dose of oseltamivir, adjusted for their renal function. Clinical improvement was documented only after a week of antiviral therapy. Despite early antiviral treatment, we showed that morbidity following novel pandemic influenza A/H1N1 2009 infection is high among kidney transplant recipients.
- Subjects :
- Antiviral Agents administration & dosage
Humans
Male
Middle Aged
Oseltamivir administration & dosage
Transplantation
Treatment Outcome
Antiviral Agents therapeutic use
Influenza A Virus, H1N1 Subtype
Influenza, Human drug therapy
Kidney Transplantation
Oseltamivir therapeutic use
Pneumonia, Viral drug therapy
Postoperative Complications drug therapy
Subjects
Details
- Language :
- English
- ISSN :
- 1399-3062
- Volume :
- 12
- Issue :
- 2
- Database :
- MEDLINE
- Journal :
- Transplant infectious disease : an official journal of the Transplantation Society
- Publication Type :
- Academic Journal
- Accession number :
- 20102550
- Full Text :
- https://doi.org/10.1111/j.1399-3062.2010.00493.x